SIMILAR PATTERNS OF AMINO ACIDS FOR 4LVC_B_ADNB501_1
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1e1c | METHYLMALONYL-COAMUTASE ALPHA CHAIN (Propionibacteriumfreudenreichii) |
PF01642(MM_CoA_mutase)PF02310(B12-binding) | 5 | LEU A 416ASP A 253GLU A 42HIS A 423GLY A 242 | None | 1.37A | 4lvcB-1e1cA:undetectable | 4lvcB-1e1cA:22.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1g7r | TRANSLATIONINITIATION FACTORIF2/EIF5B (Methanothermobacterthermautotrophicus) |
PF00009(GTP_EFTU)PF03144(GTP_EFTU_D2)PF11987(IF-2)PF14578(GTP_EFTU_D4) | 5 | LEU A 161ASP A 162ASP A 183MET A 147PHE A 146 | None | 1.16A | 4lvcB-1g7rA:undetectable | 4lvcB-1g7rA:23.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1q3k | CREATININASE (Pseudomonasputida) |
PF02633(Creatininase) | 5 | HIS A 178THR A 226HIS A 120GLY A 180MET A 40 | ZN A 300 ( 4.9A)None ZN A 300 (-3.5A)NoneNone | 1.35A | 4lvcB-1q3kA:3.2 | 4lvcB-1q3kA:19.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1v8b | ADENOSYLHOMOCYSTEINASE (Plasmodiumfalciparum) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 11 | LEU A 53HIS A 54THR A 56ASP A 134GLU A 200LYS A 230ASP A 234GLY A 397HIS A 398MET A 403PHE A 407 | NoneADN A 502 (-4.1A)ADN A 502 (-3.0A)ADN A 502 (-3.1A)ADN A 502 (-4.0A)ADN A 502 (-3.0A)ADN A 502 (-2.8A)ADN A 502 ( 3.7A)ADN A 502 ( 3.5A)ADN A 502 (-3.6A)None | 0.24A | 4lvcB-1v8bA:58.8 | 4lvcB-1v8bA:53.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2hfq | HYPOTHETICAL PROTEIN (Nitrosomonaseuropaea) |
PF09630(DUF2024) | 5 | LEU A 40LYS A 80GLY A 15HIS A 16MET A 18 | None | 1.21A | 4lvcB-2hfqA:undetectable | 4lvcB-2hfqA:10.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2pqd | 3-PHOSPHOSHIKIMATE1-CARBOXYVINYLTRANSFERASE (Agrobacteriumsp.) |
PF00275(EPSP_synthase) | 5 | THR A 275ASP A 300GLU A 299LYS A 205ASP A 201 | None | 1.38A | 4lvcB-2pqdA:undetectable | 4lvcB-2pqdA:22.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2r2d | ZN-DEPENDENTHYDROLASES (Agrobacteriumfabrum) |
PF00753(Lactamase_B) | 5 | LEU A 231HIS A 191HIS A 113GLY A 258HIS A 259 | None ZN A 278 ( 3.2A) ZN A 278 ( 3.2A)None ZN A 277 (-3.2A) | 1.47A | 4lvcB-2r2dA:undetectable | 4lvcB-2r2dA:21.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2wab | ENDOGLUCANASE E (Ruminiclostridiumthermocellum) |
PF00657(Lipase_GDSL) | 5 | HIS A 316THR A 315GLY A 306HIS A 310MET A 263 | NoneGOL A1341 (-3.7A)NoneBGC A1338 (-4.0A)BGC A1337 (-4.5A) | 1.34A | 4lvcB-2wabA:5.3 | 4lvcB-2wabA:23.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2y8u | CHITIN DEACETYLASE (Aspergillusnidulans) |
PF01522(Polysacc_deac_1) | 5 | LEU A 73HIS A 97THR A 98ASP A 48HIS A 196 | None CO A1239 ( 3.3A)None CO A1239 ( 2.4A)PO4 A1238 (-4.1A) | 1.33A | 4lvcB-2y8uA:3.6 | 4lvcB-2y8uA:17.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2z1a | 5'-NUCLEOTIDASE (Thermusthermophilus) |
PF00149(Metallophos)PF02872(5_nucleotid_C) | 5 | HIS A 215THR A 172ASP A 83ASP A 119HIS A 240 | ZN A5648 (-3.4A)None ZN A5648 (-2.7A)THM A6510 (-3.7A) ZN A5647 ( 3.5A) | 1.42A | 4lvcB-2z1aA:2.2 | 4lvcB-2z1aA:24.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2zwv | PROBABLE RIBOSOMALRNA SMALL SUBUNITMETHYLTRANSFERASE (Thermusthermophilus) |
PF05175(MTS) | 5 | LEU A 293ASP A 290HIS A 9GLY A 241PHE A 299 | NoneNoneNoneSAH A 376 (-3.1A)None | 1.38A | 4lvcB-2zwvA:3.9 | 4lvcB-2zwvA:24.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ce6 | ADENOSYLHOMOCYSTEINASE (Mycobacteriumtuberculosis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 69THR A 74ASP A 156ASP A 252HIS A 363 | ADN A 500 (-4.0A)ADN A 500 (-4.5A)ADN A 500 (-2.9A)ADN A 500 (-2.7A)ADN A 500 ( 3.7A) | 1.26A | 4lvcB-3ce6A:59.2 | 4lvcB-3ce6A:58.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ce6 | ADENOSYLHOMOCYSTEINASE (Mycobacteriumtuberculosis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 12 | LEU A 68HIS A 69THR A 71ASP A 156GLU A 218LYS A 248ASP A 252HIS A 363GLY A 415HIS A 416MET A 421PHE A 425 | NoneADN A 500 (-4.0A)ADN A 500 (-2.8A)ADN A 500 (-2.9A)ADN A 500 (-2.6A)ADN A 500 (-2.8A)ADN A 500 (-2.7A)ADN A 500 ( 3.7A)ADN A 500 ( 3.6A)ADN A 500 ( 3.6A)ADN A 500 (-3.7A)ADN A 500 (-4.8A) | 0.52A | 4lvcB-3ce6A:59.2 | 4lvcB-3ce6A:58.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3g1u | ADENOSYLHOMOCYSTEINASE (Leishmaniamajor) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 52THR A 57ASP A 130HIS A 300MET A 357 | ADN A 438 (-4.0A)ADN A 438 (-4.6A)ADN A 438 (-4.1A)ADN A 438 ( 4.0A)ADN A 438 (-3.7A) | 1.35A | 4lvcB-3g1uA:55.7 | 4lvcB-3g1uA:60.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3g1u | ADENOSYLHOMOCYSTEINASE (Leishmaniamajor) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 10 | LEU A 51HIS A 52THR A 54ASP A 130GLU A 155HIS A 300GLY A 351HIS A 352MET A 357PHE A 361 | NoneADN A 438 (-4.0A)ADN A 438 (-2.8A)ADN A 438 (-4.1A)ADN A 438 (-3.8A)ADN A 438 ( 4.0A)ADN A 438 ( 3.8A)ADN A 438 ( 3.6A)ADN A 438 (-3.7A)None | 0.50A | 4lvcB-3g1uA:55.7 | 4lvcB-3g1uA:60.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | HIS A 62THR A 67ASP A 139ASP A 233HIS A 344MET A 399 | RAB A 602 (-3.8A)RAB A 602 (-4.5A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 3.5A)RAB A 602 (-3.6A) | 1.32A | 4lvcB-3glqA:61.1 | 4lvcB-3glqA:65.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 12 | LEU A 61HIS A 62THR A 64ASP A 139GLU A 199LYS A 229ASP A 233HIS A 344GLY A 393HIS A 394MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 3.5A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.38A | 4lvcB-3glqA:61.1 | 4lvcB-3glqA:65.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3h9u | ADENOSYLHOMOCYSTEINASE (Trypanosomabrucei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 52THR A 57ASP A 130ASP A 189HIS A 300 | ADN A 439 ( 4.7A)ADN A 439 (-4.7A)NoneNAD A 438 ( 4.4A)None | 1.31A | 4lvcB-3h9uA:57.6 | 4lvcB-3h9uA:58.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3h9u | ADENOSYLHOMOCYSTEINASE (Trypanosomabrucei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 12 | LEU A 51HIS A 52THR A 54ASP A 130GLU A 155LYS A 185ASP A 189HIS A 300GLY A 351HIS A 352MET A 357PHE A 361 | NoneADN A 439 ( 4.7A)ADN A 439 (-2.7A)NoneNoneNAD A 438 ( 3.9A)NAD A 438 ( 4.4A)NoneADN A 439 (-3.5A)ADN A 439 ( 3.3A)ADN A 439 ( 3.7A)None | 0.19A | 4lvcB-3h9uA:57.6 | 4lvcB-3h9uA:58.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3n58 | ADENOSYLHOMOCYSTEINASE (Brucellaabortus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 55THR A 60ASP A 132ASP A 226HIS A 337 | ADN A 500 (-4.0A)ADN A 500 (-4.6A)ADN A 500 (-3.3A)ADN A 500 ( 2.6A)ADN A 500 ( 3.6A) | 1.24A | 4lvcB-3n58A:62.6 | 4lvcB-3n58A:69.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3n58 | ADENOSYLHOMOCYSTEINASE (Brucellaabortus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 12 | LEU A 54HIS A 55THR A 57ASP A 132GLU A 192LYS A 222ASP A 226HIS A 337GLY A 386HIS A 387MET A 392PHE A 396 | NoneADN A 500 (-4.0A)ADN A 500 (-2.8A)ADN A 500 (-3.3A)ADN A 500 (-3.6A)ADN A 500 (-2.7A)ADN A 500 ( 2.6A)ADN A 500 ( 3.6A)ADN A 500 (-3.7A)ADN A 500 (-3.4A)ADN A 500 (-3.7A)None | 0.20A | 4lvcB-3n58A:62.6 | 4lvcB-3n58A:69.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3one | ADENOSYLHOMOCYSTEINASE (Lupinus luteus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 62THR A 67ASP A 139ASP A 239HIS A 350 | ADE A 506 (-4.6A)ADE A 506 (-4.5A)NoneNAD A 501 ( 4.5A)None | 1.27A | 4lvcB-3oneA:57.6 | 4lvcB-3oneA:62.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3one | ADENOSYLHOMOCYSTEINASE (Lupinus luteus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 12 | LEU A 61HIS A 62THR A 64ASP A 139GLU A 205LYS A 235ASP A 239HIS A 350GLY A 403HIS A 404MET A 409PHE A 413 | NoneADE A 506 (-4.6A)ADE A 506 (-2.8A)NoneNoneNAD A 501 ( 4.2A)NAD A 501 ( 4.5A)NoneADE A 506 ( 3.6A)ADE A 506 (-3.4A)ADE A 506 (-3.8A)ADE A 506 (-4.9A) | 0.47A | 4lvcB-3oneA:57.6 | 4lvcB-3oneA:62.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3pf7 | BENZOYL-COAOXYGENASE COMPONENTB (Azoarcusevansii) |
no annotation | 5 | LEU A 427HIS A 423LYS A 398HIS A 406PHE A 395 | None | 0.93A | 4lvcB-3pf7A:undetectable | 4lvcB-3pf7A:20.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3rre | PUTATIVEUNCHARACTERIZEDPROTEIN (Thermotogamaritima) |
PF01256(Carb_kinase)PF03853(YjeF_N) | 5 | THR A 171ASP A 55ASP A 5GLY A 173HIS A 198 | NoneGOL A 496 (-3.1A)GOL A 496 (-2.9A)NoneNone | 1.40A | 4lvcB-3rreA:5.5 | 4lvcB-3rreA:25.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3sze | SERINE PROTEASE ESPP (Escherichiacoli) |
PF02395(Peptidase_S6) | 5 | LEU A 162THR A 148ASP A 346HIS A 411GLY A 364 | None | 1.41A | 4lvcB-3szeA:undetectable | 4lvcB-3szeA:21.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3zu0 | NAD NUCLEOTIDASE (Haemophilusinfluenzae) |
PF00149(Metallophos)PF02872(5_nucleotid_C) | 5 | LEU A 139GLU A 128ASP A 94GLY A 98HIS A 46 | NoneNone ZN A1595 (-2.4A)None ZN A1596 (-3.3A) | 1.22A | 4lvcB-3zu0A:undetectable | 4lvcB-3zu0A:22.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4c1n | CODEHYDROGENASE/ACETYL-COA SYNTHASE,IRON-SULFUR PROTEIN (Carboxydothermushydrogenoformans) |
PF03599(CdhD) | 5 | LEU B 305ASP B 31GLY B 287HIS B 288PHE B 36 | None | 1.44A | 4lvcB-4c1nB:undetectable | 4lvcB-4c1nB:22.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4gxw | ADENOSINE DEAMINASE (Burkholderiaambifaria) |
PF00962(A_deaminase) | 5 | THR A 213ASP A 300HIS A 296HIS A 240PHE A 115 | None ZN A 401 (-2.6A)NoneNoneNone | 1.42A | 4lvcB-4gxwA:undetectable | 4lvcB-4gxwA:22.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4qiw | DNA-DIRECTED RNAPOLYMERASE (Thermococcuskodakarensis) |
PF00562(RNA_pol_Rpb2_6)PF00623(RNA_pol_Rpb1_2)PF04560(RNA_pol_Rpb2_7)PF04561(RNA_pol_Rpb2_2)PF04563(RNA_pol_Rpb2_1)PF04565(RNA_pol_Rpb2_3)PF04566(RNA_pol_Rpb2_4)PF04567(RNA_pol_Rpb2_5)PF04983(RNA_pol_Rpb1_3)PF04997(RNA_pol_Rpb1_1)PF04998(RNA_pol_Rpb1_5)PF05000(RNA_pol_Rpb1_4) | 5 | LEU B1073HIS A 73LYS B1102ASP B1106GLY A 75 | None ZN A1002 (-3.1A)NoneNoneNone | 1.29A | 4lvcB-4qiwB:undetectable | 4lvcB-4qiwB:18.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5uq6 | TARTRATE-RESISTANTACID PHOSPHATASETYPE 5 (Sus scrofa) |
PF00149(Metallophos) | 5 | LEU A 95HIS A 92ASP A 146GLY A 51HIS A 186 | NonePO4 A 404 (-3.7A)PO4 A 404 ( 4.6A)None FE A 403 ( 3.4A) | 1.38A | 4lvcB-5uq6A:undetectable | 4lvcB-5uq6A:21.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5utu | ADENOSYLHOMOCYSTEINASE (Cryptosporidiumparvum) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 11 | LEU A 52HIS A 53THR A 55ASP A 137GLU A 211LYS A 241ASP A 245GLY A 409HIS A 410MET A 415PHE A 419 | NoneSAH A 502 (-4.0A)SAH A 502 (-2.7A)SAH A 502 (-3.4A)SAH A 502 (-3.8A)SAH A 502 (-2.9A)SAH A 502 (-2.8A)SAH A 502 ( 3.7A)SAH A 502 ( 3.5A)SAH A 502 (-3.6A)SAH A 502 (-4.8A) | 0.17A | 4lvcB-5utuA:54.7 | 4lvcB-5utuA:51.28 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5v96 | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE (Naegleriafowleri) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 11 | LEU A 58HIS A 59THR A 61ASP A 136GLU A 197LYS A 227ASP A 231GLY A 394HIS A 395MET A 400PHE A 404 | NoneADN A 502 ( 3.9A)ADN A 502 (-2.9A)ADN A 502 (-2.9A)ADN A 502 (-3.5A)ADN A 502 (-2.9A)ADN A 502 (-2.8A)ADN A 502 (-3.7A)ADN A 502 ( 3.4A)ADN A 502 (-3.8A)ADN A 502 (-4.9A) | 0.14A | 4lvcB-5v96A:60.6 | 4lvcB-5v96A:62.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5vyw | PYRUVATE CARBOXYLASE (Lactococcuslactis) |
PF00289(Biotin_carb_N)PF00682(HMGL-like)PF02436(PYC_OADA)PF02785(Biotin_carb_C)PF02786(CPSase_L_D2) | 5 | LEU A 604THR A 665GLU A 567ASP A 756HIS A 730 | None | 1.33A | 4lvcB-5vywA:2.1 | 4lvcB-5vywA:18.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5w4b | ADENOSYLHOMOCYSTEINASE (Homo sapiens) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | LEU A 54ASP A 131LYS A 186ASP A 190HIS A 353MET A 358PHE A 362 | NoneNoneNoneNAD A 501 (-4.1A)NAD A 501 (-4.5A)9W4 A 502 (-3.6A)None | 0.89A | 4lvcB-5w4bA:48.2 | 4lvcB-5w4bA:57.47 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5w4b | ADENOSYLHOMOCYSTEINASE (Homo sapiens) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 9 | LEU A 54HIS A 55THR A 57ASP A 131GLU A 156LYS A 186ASP A 190MET A 358PHE A 362 | None9W4 A 502 (-3.7A)9W4 A 502 (-2.9A)NoneNoneNoneNAD A 501 (-4.1A)9W4 A 502 (-3.6A)None | 0.77A | 4lvcB-5w4bA:48.2 | 4lvcB-5w4bA:57.47 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5w4b | ADENOSYLHOMOCYSTEINASE (Homo sapiens) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | LYS A 186ASP A 190GLY A 352HIS A 353MET A 358PHE A 362 | NoneNAD A 501 (-4.1A)9W4 A 502 ( 3.9A)NAD A 501 (-4.5A)9W4 A 502 (-3.6A)None | 0.94A | 4lvcB-5w4bA:48.2 | 4lvcB-5w4bA:57.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5xgs | RCC1-LIKE GEXCHANGINGFACTOR-LIKE PROTEIN (Homo sapiens) |
PF00415(RCC1)PF13540(RCC1_2) | 5 | LEU A 187HIS A 185GLY A 255HIS A 241PHE A 244 | None | 1.37A | 4lvcB-5xgsA:undetectable | 4lvcB-5xgsA:21.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6aph | ADENOSYLHOMOCYSTEINASE (Elizabethkingiaanophelis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 58THR A 63ASP A 136ASP A 195HIS A 306 | ADN A 501 (-3.9A)ADN A 501 (-4.5A)ADN A 501 (-3.0A)ADN A 501 (-2.7A)ADN A 501 ( 3.7A) | 1.22A | 4lvcB-6aphA:58.3 | 4lvcB-6aphA:60.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6aph | ADENOSYLHOMOCYSTEINASE (Elizabethkingiaanophelis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 11 | LEU A 57HIS A 58THR A 60ASP A 136GLU A 161LYS A 191ASP A 195GLY A 357HIS A 358MET A 363PHE A 367 | NoneADN A 501 (-3.9A)ADN A 501 (-2.8A)ADN A 501 (-3.0A)ADN A 501 (-2.5A)ADN A 501 (-2.8A)ADN A 501 (-2.7A)ADN A 501 (-3.6A)ADN A 501 ( 3.5A)ADN A 501 (-3.7A)None | 0.54A | 4lvcB-6aphA:58.3 | 4lvcB-6aphA:60.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6aph | ADENOSYLHOMOCYSTEINASE (Elizabethkingiaanophelis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 11 | LEU A 57HIS A 58THR A 60ASP A 136LYS A 191ASP A 195HIS A 306GLY A 357HIS A 358MET A 363PHE A 367 | NoneADN A 501 (-3.9A)ADN A 501 (-2.8A)ADN A 501 (-3.0A)ADN A 501 (-2.8A)ADN A 501 (-2.7A)ADN A 501 ( 3.7A)ADN A 501 (-3.6A)ADN A 501 ( 3.5A)ADN A 501 (-3.7A)None | 0.18A | 4lvcB-6aphA:58.3 | 4lvcB-6aphA:60.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6cey | BIFUNCTIONAL AAC/APH (Staphylococcusaureus) |
no annotation | 5 | LEU A 247ASP A 405GLY A 311HIS A 310PHE A 305 | None | 1.47A | 4lvcB-6ceyA:undetectable | 4lvcB-6ceyA:10.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6f3m | - (-) |
no annotation | 11 | HIS B 61THR B 63ASP B 139GLU B 164LYS B 194ASP B 198HIS B 323GLY B 381HIS B 382MET B 387PHE B 391 | ADN B 502 ( 4.0A)ADN B 502 (-2.8A) ZN B 505 ( 2.5A)ADN B 502 (-3.6A)ADN B 502 (-2.8A)ADN B 502 (-2.7A) ZN B 505 (-3.2A)ADN B 502 ( 3.7A)ADN B 502 (-3.4A)ADN B 502 (-3.7A)ADN B 502 (-4.9A) | 0.25A | 4lvcB-6f3mB:53.4 | 4lvcB-6f3mB:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6f3m | - (-) |
no annotation | 5 | HIS B 61THR B 66ASP B 139ASP B 198HIS B 323 | ADN B 502 ( 4.0A)ADN B 502 (-4.6A) ZN B 505 ( 2.5A)ADN B 502 (-2.7A) ZN B 505 (-3.2A) | 1.24A | 4lvcB-6f3mB:53.4 | 4lvcB-6f3mB:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6f3m | - (-) |
no annotation | 5 | HIS B 323ASP B 139GLU B 164LYS B 194GLY B 322 | ZN B 505 (-3.2A) ZN B 505 ( 2.5A)ADN B 502 (-3.6A)ADN B 502 (-2.8A)NAD B 501 (-3.4A) | 1.48A | 4lvcB-6f3mB:53.4 | 4lvcB-6f3mB:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6gbn | - (-) |
no annotation | 5 | HIS A 56THR A 61ASP A 134ASP A 193HIS A 304 | ADN A 501 (-3.9A)ADN A 501 (-4.6A)ADN A 501 (-2.9A)ADN A 501 (-2.7A)ADN A 501 ( 3.6A) | 1.21A | 4lvcB-6gbnA:58.3 | 4lvcB-6gbnA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6gbn | - (-) |
no annotation | 5 | HIS A 304ASP A 134GLU A 159LYS A 189GLY A 303 | ADN A 501 ( 3.6A)ADN A 501 (-2.9A)ADN A 501 (-3.9A)ADN A 501 (-2.9A)NAD A 502 (-3.4A) | 1.50A | 4lvcB-6gbnA:58.3 | 4lvcB-6gbnA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6gbn | - (-) |
no annotation | 12 | LEU A 55HIS A 56THR A 58ASP A 134GLU A 159LYS A 189ASP A 193HIS A 304GLY A 355HIS A 356MET A 361PHE A 365 | NoneADN A 501 (-3.9A)ADN A 501 (-2.8A)ADN A 501 (-2.9A)ADN A 501 (-3.9A)ADN A 501 (-2.9A)ADN A 501 (-2.7A)ADN A 501 ( 3.6A)ADN A 501 (-3.8A)ADN A 501 (-3.4A)ADN A 501 (-3.6A)None | 0.17A | 4lvcB-6gbnA:58.3 | 4lvcB-6gbnA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6gy5 | - (-) |
no annotation | 5 | LEU A 379HIS A 373THR A 404ASP A 374GLY A 423 | NA A 722 ( 4.4A)NoneNone NA A 721 ( 4.8A)None | 1.48A | 4lvcB-6gy5A:undetectable | 4lvcB-6gy5A:undetectable |